REYATAZ (Avera McKennan Hospital)


Welcome to the PulseAid listing for the REYATAZ drug offered from Avera McKennan Hospital. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: ATAZANAVIR
SUBSTANCE NAME: ATAZANAVIR SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-04-28
END MARKETING DATE: 0000-00-00


REYATAZ HUMAN PRESCRIPTION DRUG Details:

Item DescriptionREYATAZ from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2015-04-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-3624_0af99050-1afd-4159-a51c-660897d575db
PRODUCT NDC: 69189-3624
APPLICATION NUMBER: NDA021567

Other ATAZANAVIR SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalREYATAZ
E.R. Squibb & Sons, L.L.C.REYATAZ
Physicians Total Care, Inc.REYATAZ
RedPharm Drug, Inc.REYATAZ
REMEDYREPACK INC.REYATAZ